NSE · AI Signal & Stock Analysis · Bearish
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for SHILPAMED is Bearish ↓ (extreme move); technical trend raise-2026-08-03; trading at ₹939.50 (-2.56% today); neutral (RSI 69).
Data as of Sep 28 2026, 6:47 PM. Informational analytics only — not investment advice.
| AI signal | Bearish ↓ · Extreme move |
|---|---|
| Technical trend | RAISE-2026-08-03 |
| Price | ₹939.50 |
| Change today | -2.56% |
| RSI (14) | 69.30 |
| Relative volume | 0.65 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | ₹20,052 Cr |
| P/E | 66.66 |
| Cap category | Large Cap |
| 52-week high | -2.6% away |
| 52-week low | +251.9% above |
| Delivery volume | — |
| Sector | Drug Manufacturers - Specialty & Generic |
As of Sep 28 2026, 6:47 PM, AkshayaAI's signal for SHILPAMED (Shilpa Medicare Limited) is Bearish with a extreme move, and its technical trend is raise-2026-08-03. The composite score and full factor breakdown are available to signed-in members.
SHILPAMED's RSI is neutral (RSI 69). A reading above 70 is typically overbought and below 30 oversold.
SHILPAMED is trading about 3% below its 52-week high and 252% above its 52-week low as of Sep 28 2026, 6:47 PM.
SHILPAMED's market capitalisation is ₹20,052 Cr as of Sep 28 2026, 6:47 PM.
SHILPAMED is classified under Drug Manufacturers - Specialty & Generic in AkshayaAI's taxonomy.
AkshayaAI refreshes its signals daily. The figures on this page are timestamped as of the latest run shown above.
No. AkshayaAI provides informational, AI-generated analytics for SHILPAMED — not personalised investment advice. Always do your own research.
AARTIPHARM · ABBOTINDIA · AJANTPHARM · AKUMS · ALIVUS · ALKEM
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Sep 28 2026, 6:47 PM and may not reflect real-time prices. Always do your own research. How these signals work →
Instant, data-backed answers — free to try.